Neuronetics Stock Market Value
| STIM Stock | USD 1.34 0.08 5.63% |
| Symbol | Neuronetics |
Will Health Care Equipment & Supplies sector continue expanding? Could Neuronetics diversify its offerings? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuronetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
Neuronetics's market price often diverges from its book value, the accounting figure shown on Neuronetics's balance sheet. Smart investors calculate Neuronetics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Neuronetics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Neuronetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neuronetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neuronetics.
| 12/01/2025 |
| 03/01/2026 |
If you would invest 0.00 in Neuronetics on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding Neuronetics or generate 0.0% return on investment in Neuronetics over 90 days. Neuronetics is related to or competes with Prenetics Global, Nyxoah, Atlantic International, OmniAb, Perspective Therapeutics, OraSure Technologies, and Profound Medical. Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients w... More
Neuronetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neuronetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neuronetics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.2 | |||
| Information Ratio | 0.0269 | |||
| Maximum Drawdown | 35.51 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 10.95 |
Neuronetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neuronetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neuronetics' standard deviation. In reality, there are many statistical measures that can use Neuronetics historical prices to predict the future Neuronetics' volatility.| Risk Adjusted Performance | 0.039 | |||
| Jensen Alpha | 0.0232 | |||
| Total Risk Alpha | (0.48) | |||
| Sortino Ratio | 0.0313 | |||
| Treynor Ratio | 0.0873 |
Neuronetics March 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.039 | |||
| Market Risk Adjusted Performance | 0.0973 | |||
| Mean Deviation | 5.67 | |||
| Semi Deviation | 6.0 | |||
| Downside Deviation | 6.2 | |||
| Coefficient Of Variation | 2545.14 | |||
| Standard Deviation | 7.23 | |||
| Variance | 52.31 | |||
| Information Ratio | 0.0269 | |||
| Jensen Alpha | 0.0232 | |||
| Total Risk Alpha | (0.48) | |||
| Sortino Ratio | 0.0313 | |||
| Treynor Ratio | 0.0873 | |||
| Maximum Drawdown | 35.51 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 10.95 | |||
| Downside Variance | 38.46 | |||
| Semi Variance | 35.97 | |||
| Expected Short fall | (6.52) | |||
| Skewness | 0.7524 | |||
| Kurtosis | 1.03 |
Neuronetics Backtested Returns
As of now, Neuronetics Stock is dangerous. Neuronetics has Sharpe Ratio of 0.022, which conveys that the firm had a 0.022 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Neuronetics, which you can use to evaluate the volatility of the firm. Please verify Neuronetics' Risk Adjusted Performance of 0.039, mean deviation of 5.67, and Downside Deviation of 6.2 to check out if the risk estimate we provide is consistent with the expected return of 0.16%. Neuronetics has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 3.14, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neuronetics will likely underperform. Neuronetics right now secures a risk of 7.31%. Please verify Neuronetics downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Neuronetics will be following its current price movements.
Auto-correlation | -0.5 |
Modest reverse predictability
Neuronetics has modest reverse predictability. Overlapping area represents the amount of predictability between Neuronetics time series from 1st of December 2025 to 15th of January 2026 and 15th of January 2026 to 1st of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neuronetics price movement. The serial correlation of -0.5 indicates that about 50.0% of current Neuronetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Neuronetics Correlation, Neuronetics Volatility and Neuronetics Performance module to complement your research on Neuronetics. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Neuronetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.